MRI features suggestive of gadolinium retention do not correlate with Expanded Disability Status Scale worsening in Multiple Sclerosis-Reference-Cited by-同舟云学术

MRI features suggestive of gadolinium retention do not correlate with Expanded Disability Status Scale worsening in Multiple Sclerosis

Published:2019-01-08 Issue:2 Volume:61 Page:155-162
ISSN:0028-3940
Container-title:Neuroradiology
language:en
Short-container-title:Neuroradiology

Author:

Cocozza Sirio^ORCID,Pontillo Giuseppe,Lanzillo Roberta,Russo Camilla,Petracca Maria,Di Stasi Martina,Paolella Chiara,Vola Elena Augusta,Criscuolo Chiara,Moccia Marcello,Lamberti Anna,Monti Serena,Brescia Morra Vincenzo,Elefante Andrea,Palma Giuseppe,Tedeschi Enrico,Brunetti Arturo

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Neurology (clinical),Radiology, Nuclear Medicine and imaging

Link

http://link.springer.com/article/10.1007/s00234-018-02150-4/fulltext.html

Reference41 articles.

1. Aime S, Caravan P (2009) Biodistribution of gadolinium-based contrast agents, including gadolinium deposition. J Magn Reson Imaging 30(6):1259–1267. https://doi.org/10.1002/jmri.21969

2. Kanal E, Maravilla K, Rowley HA (2014) Gadolinium contrast agents for CNS imaging: current concepts and clinical evidence. AJNR Am J Neuroradiol 35(12):2215–2226. https://doi.org/10.3174/ajnr.A3917

3. Jung JW, Kang HR, Kim MH, Lee W, Min KU, Han MH, Cho SH (2012) Immediate hypersensitivity reaction to gadolinium-based MR contrast media. Radiology 264(2):414–422. https://doi.org/10.1148/radiol.12112025

4. Grobner T (2006) Gadolinium—a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 21(4):1104–1108. https://doi.org/10.1093/ndt/gfk062

5. McDonald RJ, Levine D, Weinreb J, Kanal E, Davenport MS, Ellis JH, Jacobs PM, Lenkinski RE, Maravilla KR, Prince MR, Rowley HA, Tweedle MF, Kressel HY (2018) Gadolinium retention: a research roadmap from the 2018 NIH/ACR/RSNA workshop on gadolinium chelates. Radiology 181151:517–534. https://doi.org/10.1148/radiol.2018181151

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safe and Informed Use of Gadolinium-Based Contrast Agent in Body Magnetic Resonance Imaging: Where We Were and Where We Are;Journal of Clinical Medicine;2024-04-10

2. Clinical Safety of Gadobutrol: Review of Over 25 Years of Use Exceeding 100 Million Administrations;Investigative Radiology;2024-03-01

3. Utilização de Gadolínio nas Ressonâncias Magnéticas de Controlo em Doentes com Esclerose Múltipla: Recomendações Atuais;Acta Médica Portuguesa;2024-01-03

4. Update on Gadolinium Based Contrast Agent Safety, From the AJR Special Series on Contrast Media;American Journal of Roentgenology;2023-10-18

5. Ten years of gadolinium retention and deposition: ESMRMB-GREC looks backward and forward;European Radiology;2023-10-07